NCT00154193View on ClinicalTrials.gov

Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels

PHASE4CompletedINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

November 30, 2007

Conditions

Heart and Lung Transplant

Interventions

DRUG

cyclosporine

patients will receive maintenance triple immunosuppression according to local practice consisting of Sandimmun Neoral, MMF/ECMPA or azathioprin and steroids.

Trial Locations (1)

Unknown

Novartis, Basel